Machine signal
Active cluster sell — 5 distinct insiders, $2.3M, window ends Sep 16, 2026.
Figures computed from official regulatory filings — .
Analysttarget 37 USD (+47%) · consensus 4.43/5 · 6 buy · 1 hold · 0 sell
Ownershipinsiders 1.77% · institutions 108.71% · short 15.7% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Arcutis Biotherapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. The company's lead product is ZORYVE, a topical roflumilast cream for the treatment of plaque psoriasis and atopic dermatitis. It also develops ZORYVE foam seborrheic dermatitis, and scalp and body psoriasis treatment; ARQ-234, a fusion protein that is a potent and highly selective checkpoint agonist of the CD200 receptor. The company was formerly known as Arcutis, Inc. and changed its name to Arcutis Biotherapeutics, Inc. in October 2019. Arcutis Biotherapeutics, Inc. was incorporated in 2016 and is headquartered in Westlake Village, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
29 buys345 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| Matsuda Masaru | Sell | $91.9K | SEC |
| Welgus Howard G. | Sell | $114.4K | SEC |
| Welgus Howard G. | Exercise | $19.5K | SEC |
| Welgus Howard G. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Welgus Howard G. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Welgus Howard G. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Welgus Howard G. | Exercise | $7.7K | SEC |
| Welgus Howard G. | Exercise | $5.4K | SEC |
| Matsuda Masaru | Sell | $250K | SEC |
| Curran Terrie | Sell | $279K | SEC |
| Curran Terrie | Exercise | $233.5K | Unusual size | SEC |
| Curran Terrie | Sell | $677.1K | SEC |
| Curran Terrie | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Curran Terrie | Exercise | $83.7K | SEC |
| Curran Terrie | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Curran Terrie | Exercise | $8.1K | SEC |
| Curran Terrie | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Curran Terrie | Sell | $27.9K | SEC |
| Burnett Patrick | Sell | $45.8K | SEC |
| Welgus Howard G. | Sell | $123.8K | SEC |
| Welgus Howard G. | Exercise | $5.4K | SEC |
| Welgus Howard G. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Welgus Howard G. | Exercise | $7.7K | SEC |
| Welgus Howard G. | Exercise | $19.5K | Unusual size | SEC |
| Welgus Howard G. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |